Cognition and neuropathology in schizophrenia

Acta Psychiatrica Scandinavica, Supplement

Volumn 99, Issue 395, 1999, Pages 41-50

  Arnold, S E ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b 142 Clinical Research Building ^*  (United States)

Author keywords

Cognition; Neuropathology; Schizophrenia

Indexed keywords

CELL DENSITY; CELL SIZE; COGNITION; CONFERENCE PAPER; CYTOARCHITECTURE; FRONTAL LOBE; HISTOPATHOLOGY; LIMBIC CORTEX; NERVE CELL NETWORK; NERVE DEGENERATION; NERVE INJURY; NERVOUS SYSTEM DEVELOPMENT; NEUROPATHOLOGY; PATHOPHYSIOLOGY; SCHIZOPHRENIA; TEMPORAL LOBE; BIOLOGICAL MODEL; BRAIN; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DISEASE COURSE; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIMBIC SYSTEM; NERVE TRACT; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PSYCHOLOGY; REVIEW;

BRAIN; COGNITION DISORDERS; DISEASE PROGRESSION; FRONTAL LOBE; HUMANS; LIMBIC SYSTEM; MODELS, NEUROLOGICAL; NERVE DEGENERATION; NEURAL PATHWAYS; NEURODEGENERATIVE DISEASES; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TEMPORAL LOBE;

EID: 0032609343     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1999.tb05982.x     Document Type: Conference Paper

References (106)

1. DAVID GB. The pathological anatomy of the schizophrenias. In: RICHTER D, ed. Schizophrenia: somatic aspects. Oxford: Pergamon Press, 1957:93-130.
2. Proceedings of the First International Congress of Neuropathology. Turin, Italy: Rosenberg and Sellier, 1952.
3. DAVIS KL, KAHN RS, KO G, DAVIDSON M. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 1992;148:1474-1486.
4. BOGERTS B. Recent advances in the neuropathology of schizophrenia. Schizophr Bull 1993;19:431-445.
5. OHUOHA DC, HYDE TM, KLEINMAN JE. The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system. Psychopharmacology 1993;112 (Suppl. 1.):S5-15.
6. SHAPIRO RM. Regional neuropathology in schizophrenia. Where are we? Where are we going? Schizophr Res 1993;10:187-239.
7. ARNOLD SE, TROJANOWSKI JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol 1996;92:217-231.
8. DAVIDSON K. Schizophrenia-like psychoses associated with organic cerebral disorders: a review. Psychiatr Dev 1983;1:1-34.
9. GOLDBERG TE, KELSOE JR, WEINBERGER DR, PLISKIN NH, KIRWIN PD, BERMAN KF. Performance of schizophrenic patients on putative neuropsychological tests of frontal lobe function. Int J Neurosci 1988;42:51-58.
10. GRUZELIER J, SEYMOUR K, WILSON J. Impairments on neuropsychological tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenic and affective disorders. Arch Gen Psychiatry 1988;45:623-629.
11. SAYKIN AJ, GUR RC, GUR RE et al. Neuropsychological function in schizophrenia: selective impairment in memory and learning. Arch Gen Psychiatry 1991;48:618-624.
12. KOPALA LC, CLARK C, HURWITZ T. Olfactory deficits in neuroleptic naive patients with schizophrenia. Schizophr Res 1992;8:245-250.
13. WU J, BUCHSBAUM MS, MOY K et al. Olfactory memory in unmedicated schizophrenics. Schizophr Res 1993;9:41-47.
14. MOBERG PJ, DOTY RL, TURETSKY BI et al. Olfactory identification deficits in schizophrenia: correlation with duration of illness. Am J Psychiatry 1997;154:1016-1018.
15. CORNBLATT BA, KEILP JG. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull 1994;20:31-46.
16. TAYLOR SF. Cerebral blood flow activation and functional lesions in schizophrenia. Schizophr Res 1996;19:129-140.
17. VELAKOULIS D, PANTELIS C. What have we learned from functional imaging studies in schizophrenia? The role of frontal, striatal and temporal areas. Austr NZ J Psychiatry 1996;30:195-209.
18. FRISTON KJ, LIDDLE PF, FRITH CD, HIRSCH SR, FRACKOWIAK RS. The left medial temporal region and schizophrenia. A PET study. Brain 1992;115:367-382.
19. SCHROEDER J, BUCHSBAUM MS, SIEGEL BV, GEIDER FJ, NIETHAMMER R. Structural and functional correlates of subsyndromes in chronic schizophrenia. Psychopathology 1995;28:38-45.
20. SILBERSWEIG DA, STERN E, FRITH C et al. A functional neuroanatomy of hallucinations in schizophrenia. Nature 1995;378:176-179.
21. SAYKIN AJ, RIORDAN HJ, WEAVER JB et al. Memory activation in schizophrenia - preliminary observations using functional magnetic resonance imaging (FMRI). Schizophr Res 1995;15:97.
22. DAVID AS, WOODRUFF PW, HOWARD R et al. Auditory hallucinations inhibit exogenous activation of auditory association cortex. Neuroreport 1996;7:932-936.
23. YURGELIN-TODD DA, WATERNAUX CM, COHEN BM, GRUBER SA, ENGLISH CD, RENSHAW PF. Functional magnetic resonance imaging of schizophrenic patients and comparison subjects during word production. Am J Psychiatry 1996;153:200-205.
24. FALKAI P, BOGERTS B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 1986;236:154-161.
25. FALKAI P, BOGERTS B, ROZUMEK M. Limbic pathology in schizophrenia: the entorhinal region - a morphometric study. Biol Psychiatry 1988;24:515-521.
26. JESTE DV, LPHR JB. Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch Gen Psychiatry 1989;46:1019-1024.
27. HOLINGER DP, ROSEN GD, GALABURDA AM. Decreased neuroneal density in the supragranular layer of area Tpt of the superior temporal gyrus of schizophrenics. Soc Neurosci Abstr 1995;21:238.
28. KOVELMAN JA, SCHEIBEL AB. A neurohistological correlate of schizophrenia. Biol Psychiatry 1984;19:1601-1621.
29. BENES FM, SORENSEN I, BIRD ED. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophr Bull 1991;17:597-608.
30. ARNOLD SE, FRANZ BR, GUR RC et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry 1995;152:738-748.
31. HECKERS S, HEINSEN H, GEIGER B, BECKMANN H. Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry 1991;48:1002-1008.
32. BENES FM, DAVIDSON J, BIRD ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry 1986;43:31-35.
33. BENES FM, McSPARREN J, BIRD ED, SANGIOVANNI JP, VINCENT SL. Deficits in small interneurones in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991;48:996-1001.
34. AKBARIAN S, KIM JJ, POTKIN SG et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurones in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 1995;52:258-266.
35. SELEMON LD, RAJKOWSKA G, GOLDMAN-RAKIC PS. Abnormally high neuronal density in the schizophrenic cortex: a morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry 1995;52:805-818.
36. RAJKOWSKA G, SELEMON LD, GOLDMAN-RAKIC PS. Reduction in neuronal sizes in prefronlal cortex of schizophrenics and Huntington patients. Soc Neurosci Abstr 1994;20:620.
37. LOHR JB, JESTE DV. Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand 1988;77:689-697.
38. PAKKENBERG B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenia. Arch Gen Psychiatry 1990;47:1023-1028.
39. KARSON CN, GARCIA-RILL E, BIEDERMANN J, MRAK RE, HUSAIN MM, SKINNER RD. The brainstem reticular formation in schizophrenia. Psychiatr Res 1991;40:31-48.
40. SPITZER M, BRAUN U, HERMLE L, MAIER S. Associative semantic network dysfunction in thought-disordered patients: direct evidence from indirect semantic priming. Biol Psychiatry 1994;34:864-877.
41. SPITZER M, WEISKER I, WINTER M, MAIER S, HERMLE L, MAHER BA. Semantic and phonologic priming in schizophrenia. J Abnorm Psychol 1994;103:484-495.
42. FRISTON KJ, FRITH CD. Schizophrenia: a disconnection syndrome? Clin Neurosci 1995;3:89-97.
43. BENES FM. Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr Bull 1993;19:537-549.
44. BENES FM, TODTENKOPF MS, TAYLOR JB. A shift in tyrosine hydroxylase-immunoreactive varicosities (ITH-IRv) for pyramidal (PN) to nonpyramidal (NP) neurones occurs in layer II of the anterior cingulate cortex of schizoprenics. Soc Neurosci Abstr 1995;21:259.
45. POWCHIK P, GABRIEL SM, HAROUTUNIAN V et al. Cortical synaptic membrane immunoreactivity in schizophrenia contrasts with Alzheimer's disease. Soc Neurosci Abstr 1994;20:623.
46. SOWER AC, BELUE R, BIRD ED, PERRONE-BIZZOZERO NI. Altered GAP-43 and synaptophysin levels in visual association cortices from schizophrenic brains. Soc Neurosci Abstr 1994;20:621.
47. PERRONE-BIZZOZERO NI, SOWER AC, BIRD ED, BENOWITZ LI, IVINS KJ, NEVE RL. Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc Natl Acad Sci USA 1996;93:14182-14187.
48. GLANTZ LA, LEWIS DA. Synaptophysin and not RAB3A is specifically reduced in the prefrontal cortex of schizophrenic subjects. Soc Neurosci Abstr 1994;20:622.
49. STEFAN MD, ROYSTAN MC, FALKAI P, GENTLEMAN S, ROBERTS GW. SNAP25: study of a new synaptic marker in schizophrenia. Schizophr Res 1995:236.
50. BROWNING MD, DUDEX EM, RAPIER JL, LEONARD S, FREEDMAN R. Significant reductions in synapsin- but not synaptophysin-specific activity in the brains of some schizophrenics. Biol Psychiatry 1993;34:529-535.
51. EASTWOOD SL, BURNET PWJ, HARRISON PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neurosci 1995;66:309-319.
52. WEINBERGER DR. From neuropathology to neurodevelopment. Lancet 1995;346:552-557.
53. McGUFFIN P, ANDERSON P, OWEN M et al. The strength of the genetic effect: is there room for an environmental influence in the aetiology of schizophrenia? Br J Psychiatry 1994;164:593-599.
54. MEDNICK SA, MACHON RA, HUTTUNEN MO, BONNETT D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988;45:189-192.
55. CANNON TD, MEGGISON-HOLLISTER J, BEARDEN CE, HADLEY T. A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Under review.
56. HOLLISTER JM, LAING P, MEDNICK SA. Rhesus incompatibility as a risk factor for schizophrenia in male adults. Arch Gen Psychiatry 1996;53:19-24.
57. SUSSER E, NEUGEBAUER R, HOEK HW et al. Schizophrenia after prenatal famine. Arch Gen Psychiatry 1996;53:25-31.
58. O'CALLAGHAN E, LARKIN C, KINSELLA A, WADDINGTON JL. Familial, obstetric and other clinical correlates of minor physical anomalies in schizophrenia. Am J Psychiatry 1991;148:479-483.
59. McNEIL TF, CANTOR-GRAAE E, NORDSTROM LG, ROSENLUNG T. Head circumference in 'preschizophrenics' and control neonates. Br J Psychiatry 1993;162:517-523.
60. WALKER E. Developmentally moderated expressions of the neuropathology underlying schizophrenia. Schizophr Bull 1994;20:453-480.
61. JONES P, RODGERS B, MURRAY R, MARMOT M. Child development risk factors for adult onset schizophrenia in the British 1946 birth cohort. Lancet 1994;344:1398-1402.
62. CONRAD AJ, ABEBE T, AUSTIN R, FORSYTHE S, SCHEIBEL AB. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Arch Gen Psychiatry 1991;48:413-417.
63. JAKOB H, BECKMANN H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986;65:303-326.
64. ARNOLD SE, HYMAN BT, HOESEN GWV, DAMASIO AR. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch Gen Psychiatry 1991;48:625-632.
65. KRIMER LS, HERMAN MM, SAUNDERS RC et al. Qualitative and quantitative analysis of the entorhinal cortex cytoarchitectural organization in schizophrenia. Soc Neurosci Abstr 1995;21:239.
66. ARNOLD SE, RUSCHEINSKY DR, HAN L-Y. Further evidence of abnormal cytoarchitecture of the entorhinal cortex in schizophrenia using spatial point pattern analyses. Biol Psychiatry 1997;42:639-647.
67. BARBEAU D, LIANG JJ, ROBITAILLE Y, QUIRION R, SRIVASTAVA LK. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci USA 1995;92:2785-2789.
68. ARNOLD SE, LEE VMY, GUR RE, TROJANOWSKI JQ. Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia. Proc Natl Acad Sci USA 1991;88:10850-10854.
69. AKBARIAN S, BUNNEY WE, POTKIN SG et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993;50:169-177.
70. AKBARIAN S, VINUELA A, KIM JJ, POTKIN SG, BUNNEY WE, JONES EG. Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurones in temporal lobe of schizophrenics implies anomalous cortical development. Arch Gen Psychiatry 1993;50:178-187.
71. AKBARIAN S, KIM JJ, POTKIN SG, HETRICK WP, BUNNEY WE, JONES EG. Maldistribution of interstitial neurones in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatry 1996;53:425-436.
72. BLEULER M. A 23-year longitudinal study of 208 schizophrenics and impressions in regard to the nature of schizophrenia. In: ROSENTHAL D, KETY SS, ed. The transmission of schizophrenia. New York: Pergamon Press, 1968:3-12.
73. CIOMPI L. Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophr Bull 1980;6:606-618.
74. WINOKUR G, PFOHL B, TSUANG M. A 40-year follow-up of hebephrenic-catatonic schizophrenia. In: MILLER N, COHEN G, ed. Schizophrenia and aging. New York: Guilford Press, 1987:52-60.
75. CARPENTER WT, KIRKPATRICK B. The heterogeneity of the long-term course of schizophrenia. Schizophr Bull 1988;14:515-542.
76. LINDSTROM LH. Clinical and biological markers for outcome in schizophrenia. Neuropsychopharmacology 1996;14:23S-26S.
77. NOPOULOS P, FLASHMNA L, FLAUM M, ARNDT S, ANDREASEN N. Stability of cognitive functioning early in the course of schizophrenia. Schizophr Res 1994;14:29-37.
78. SAYKIN AJ, SHTASEL DL, GUR RE et al. Neuropsychological deficits in neuroleptic-naive patients with first-episode schizophrenia. Arch Gen Psychiatry 1994;51:124-131.
79. CHEN EY, LAM LC, CHEN RY, NGUYEN DG, CHAN CK. Prefrontal neuropsychological impairment and illness duration in schizophrenia: a study of 204 patients in Hong Kong. Acta Psychiatr Scand 1996;93:144-150.
80. WADDINGTON JL, YOUSSEF HA. Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychol Med 1996;26:681-688.
81. HYDE TM, NAWROZ, S, GOLDBERG TE et al. Is there cognitive decline in schizophrenia? A cross-sectional study. Br J Psychiatry 1994;164:494-500.
82. DAVIDSON M, HARVEYPD, POWCHIK P et al. Severity of symptoms in chronically institutionalized geriatric schizophrenic patients. Am J Psychiatry 1995;152:197-207.
83. ARNOLD SE, GUR RE, SHAPIRO RM et al. Prospective clinicopathological studies of schizophrenia: accrual and assessment. Am J Psychiatry 1995;152:731-737.
84. HARVEY PD, LOMBARDI J, KINCAID MM et al. Cognitive functioning in chronically hospitalized schizophrenic patients: age-related changes and age disorientation as a predictor of impairment. Schizophr Res 1995;17:15-24.
85. MOBERG PJ, MAHR R, GIBNEY M et al. Neuropsychological functioning in elderly patients with schizophrenia and Alzheimer's disease. J Int Neuropsychol Soc 1995;1:132.
86. PUROHTT DP, DAVIDSON M, PERL DP et al. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biol Psychiatry 1993;33:255-260.
87. ARNOLD SE, FRANZ BR, TROJANOWSKI JQ. Elderly patients with schizophrenia exhibit infrequent neurodegenerative lesions. Neurobiol Aging 1994;15:299-303.
88. LARSON EB, REIFLER BV, FEATHERSTONE HJ, ENGLISH DR. Dementia in elderly outpatients: a prospective study. Ann Intern Med 1984;100:417-423.
89. POWCHIK P, DAVIDSON M, NEMEROFF CB et al. Alzheimer's disease-related protein in geriatric schizophrenic patients with cognitive impairment. Am J Psychiatry 1993;150:1726-1727.
90. TALLER AM, ASMER DM, POMEROY KL et al. Search for viral nucleic acid sequences in brain tissues of patients with schizophrenia using nested polymerase chain reaction. Arch Gen Psychiatry 1996;53:32-40.
91. STEVENS JR. Neuropathology of schizophrenia. Arch Gen Psychiatry 1982;39:1131-1139.
92. BRUTON CJ, CROW TJ, FRITH CD, JOHNSTONE EC, OWENS DGC, ROBERTS GW. Schizophrenia and the brain: a prospective clinico-neuropathological study. Psychol Med 1990;20:285-304.
93. ROBERTS GW, COLTER N, LOFTHOUSE R, JOHNSTONE EC, CROW TJ. Is there gliosis in schizophrenia? Investigation of the temporal lobe. Biol Psychiatry 1987;22:1459-1468.
94. Stevens CD, Altshuler LL, Boberts B, Falkai P. Quantitative study of gliosis in schizophrenia and Huntington's chorea. Biol Psychiatry 1988;24:697-700.
95. CROW TJ, BALL J, BLOOM SR et al. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry 1989;46:1145-1150.
96. ARNOLD SE, TROJANOWSKI JQ, GUR RE, HAN L-Y, CHOI C. Investigations of neurodegeneration and neural injury in the brains of elderly patients with schizophrenia. Arch Gen Psychiatry 1998;55:225-232.
97. OLNEY JW, FARBER NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998-1007.
98. MATTSON MP. Cellular signaling mechanisms common to the development and degeneration of neuroarchitecture. A review. Mech Ageing Dev 1989;50:103-157.
99. EASTWOOD SL, McDONALD B, BURNET PW, BECKWITH JP, KERWIN RW, HARRISON PJ. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurones in schizophrenia. Brain Research. Mol Brain Res 1995;29:211-223.
100. TSAI G, PASSAMO LA, SLUSHER BS et al. Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch Gen Psychiatry 1995;52:829-836.
101. THOENEN H. Neurotrophins and neuronal plasticity. Science 1995;270:593-598.
102. HENDERSON CE. Role of neurotrophic factors in neuronal development. Curr Opin Neurobiology 1996;6:64-70.
103. SMITH MA. Hippocampal vulnerability to stress and aging: possible role of neurotrophic factors. Behav Brain Res 1996;78:25-36.
104. BROUHA AK, WEICKERT CS, HYDE TM et al. Reductions in brain-derived neurotrophic factor mRNA in the hippocampus of patients with schizophrenia. Soc Neurosci Abstr 1996;22:1680.
105. BAILEY CH, BARTSCH D, KANDEL ER. Towards a molecular definition of long-term memory storage. Proc Natl Acad Sci USA 1996;93:13445-13452.
106. NIBUYA M, NESTLER EJ, DUMAN RS. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 1996;16:2365-2372.